Rosslyn Data Tech. - Contract renewals worth $1.5m
Rosslyn Data Technologies plc
("Rosslyn" or the "Company")
Contract renewals worth
Two contract extensions and a service expansion with AICE adoption
Rosslyn (AIM: RDT), the provider of a leading cloud-based spend intelligence platform, is pleased to announce that it has secured contract renewals with two of its long-standing customers, which are worth a total of
· A multinational medical devices and healthcare company headquartered in the US has signed a three-year renewal of its annual licence to utilise the Rosslyn platform. The customer will also adopt the Company's Artificial Intelligence Classification Engine ("AICE") tool for the first time as part of the renewal. The renewed and expanded contract is worth a total of
· One of the world's leading media and entertainment companies has signed a one-year renewal of its annual licence to utilise the Rosslyn platform for
This announcement contains inside information as stipulated under the Market Abuse Regulations (
Enquiries
|
Rosslyn |
|
|
|
+44 (0)20 3285 8008
|
|
|
|
|
Cavendish Capital Markets Limited (Nominated adviser and Broker) |
|
|
|
+44 (0)20 7220 0500 |
|
|
|
|
Gracechurch Group (Financial PR) |
|
|
Claire Norbury/Anysia Virdi |
++44 (0)20 4582 3500 |
About Rosslyn
Rosslyn (AIM: RDT) provides an award-winning spend intelligence and predictive analytics platform. The Rosslyn Platform helps organizations with diverse supply chains mitigate risk and make informed strategic decisions. It leverages automated workflows, artificial intelligence and machine learning to extract and consolidate procurement data providing visibility of complex supplier data, enabling supplier spend savings and delivering rapid ROI. For more information visit www.rosslyn.ai. Investors wishing to contact the Company should email investors@rosslyn.ai.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE